Anika Therapeutics buy Barrington Research
Start price
09.05.24
/
50%
€23.40
Target price
09.05.25
€34.32
Performance (%)
-2.56%
Price
04.10.24
€22.80
Summary
This prediction is currently active. With a performance of -2.56%, the BUY prediction by Barrington_Research is trending in the wrong direction. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Anika Therapeutics | 3.636% | 3.636% |
iShares Core DAX® | -1.114% | 5.062% |
iShares Nasdaq 100 | 1.816% | 9.828% |
iShares Nikkei 225® | 2.113% | 8.218% |
iShares S&P 500 | 2.038% | 7.448% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
10.68%
04.10.24
04.10.24
Anika Therapeutics
Start price
Target price
Perf. (%)
€19.70
03.11.23
03.11.23
€26.08
03.11.24
03.11.24
15.74%
04.10.24
04.10.24